Functional and immunological characteristics of specific CfrA antibodies. (A) Inhibitory effect of anti-CfrA IgG on enterobactin-mediated growth promotion in C. jejuni. Purified CfrA IgG (320 μg/ml), control IgG (320 μg/ml, from preimmune serum), or PBS was mixed with C. jejuni NCTC 11168 cells for a modified growth promotion assay as described in Materials and Methods. (B) Dose-dependent inhibitory effect of anti-CfrA IgG on enterobactin-mediated growth promotion in C. jejuni. Approximately 1 × 108 C. jejuni cells were inoculated onto iron-restricted MH agar supplemented with PBS (PBS control), 320 μg/ml of IgG from preimmune serum (IgG control), or anti-CfrA IgG at various concentrations, including 320 μg/ml (IgG 320), 64 μg/ml (IgG 64), 32 μg/ml (IgG 32), and 12.8 μg/ml (IgG 12.8). The bars and error bars indicate the means ± standard deviations of the growth zone diameter for four independent measurements. (C) Immunoblot analysis of in vivo antibody responses to CfrA. rCfrA was blotted with individual chicken serum samples (lanes 2 to 5) or with the rabbit anti-CfrA antibody (positive control) (lane 6). Lane 2, serum sample from a 7-week-old broiler chicken infected with C. jejuni S3B; lane 3, serum sample from a 2-day-old broiler chicken with a high level of maternal antibodies against C. jejuni; lanes 4 and 5, serum samples from 3-week-old broiler chickens which were free of Campylobacter. Prestained molecule mass markers (Bio-Rad) (lane 1) were coelectrophoresed and blotted to estimate the sizes of the proteins.